Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Che-Hsuan Lin"'
Autor:
Kuan-Chou Chen, Hui Yu Lin, Yuan Feng Lin, Hsun-Hua Lee, Jing-Quan Zheng, Che-Hsuan Lin, Chia-Hao Kuei
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 4
Journal of Clinical Medicine, Vol 9, Iss 956, p 956 (2020)
Volume 9
Issue 4
Journal of Clinical Medicine, Vol 9, Iss 956, p 956 (2020)
Background: Although mTOR inhibitors have been approved as a first-line therapy for treating metastatic clear cell renal cell carcinoma (ccRCC), the lack of useful markers reduces their therapeutic effectiveness. We investigated whether IMPA2 downreg
Autor:
Che Hsuan Lin, Long Sheng Lu, Hui Yu Lin, Jungshan Chang, Chia Hao Kuei, Yuan Feng Lin, Jia Yi Wang, Hsun Hua Lee, Kai Cheng Hsu, Fei Peng Lee
Publikováno v:
Journal of Clinical Medicine
Volume 8
Issue 9
Journal of Clinical Medicine, Vol 8, Iss 9, p 1454 (2019)
Volume 8
Issue 9
Journal of Clinical Medicine, Vol 8, Iss 9, p 1454 (2019)
Radiotherapy is commonly used to treat patients with oral squamous cell carcinoma (OSCC), but a subpopulation of OSCC patients shows a poor response to irradiation treatment. Therefore, identifying a biomarker to predict the effectiveness of radiothe
Autor:
Jing Quan Zheng, Kuan-Chou Chen, Ruei Chen Hung, Min-Hsuan Lin, Hui Yu Lin, Chia Hao Kuei, Wei Jiunn Lee, Yuan Feng Lin, Che Hsuan Lin, Yen-Lin Chen, Hui Wen Chiu, Long Sheng Lu, Hsun Hua Lee
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866:165954
Objective Docetaxel remains a main treatment for metastatic castration-resistant prostate cancer (mCRPC); however, the development of docetaxel resistance has been found in some mCRPC patients. The aim of this work is to identify an effective biomark
Autor:
Long Sheng Lu, Yuan Feng Lin, Hsun-Hua Lee, Fei Peng Lee, Lung-Che Chen, Wei Min Chang, Che-Hsuan Lin
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2690, p 2690 (2020)
Volume 12
Issue 9
Cancers, Vol 12, Iss 2690, p 2690 (2020)
Volume 12
Issue 9
Radiotherapy is commonly used to treat oral cancer patients in the current clinics
however, a subpopulation of patients shows poor radiosensitivity. Therefore, the aim of this study is to identify a biomarker or druggable target to enhance the e
however, a subpopulation of patients shows poor radiosensitivity. Therefore, the aim of this study is to identify a biomarker or druggable target to enhance the e